2017 -
2021 Engineering Specialist, Research and Advanced Technologies @
2014 -
2017 Sr. Principal Engineer, Research and Advanced Technologies @
2012 -
2014 Principal Engineer, Research and Advanced Technologies @
2010 -
2012 Senior Engineer, Research and Advanced Technologies @
2009 -
2010 Systems Test Engineer @
2008 -
2009 Teaching Assistant @
2007 -
2008 Project Manager @
2006 -
2007 Engineering Tech @ Wicab, Inc.
Chris Wegener Education
University of Wisconsin-Madison
MS (Biomedical Engineering)
2008
-
2009
University of Wisconsin-Madison
BS (Biomedical Engineering)
2003
-
2007
Chris Wegener Skills
Biomedical Engineering
Medical Device Product Development
Matlab
Telelogic DOORS
Concept Design
Concept Development
Blood Processing Systems
Product Design
Medical Devices
Product Development
Validation
Data Analysis
Engineering
Testing
R&D
Design of Experiments
Cross-functional Team Leadership
Design Control
ISO 13485
Research and Development (R&D)
Research and Development R&d
Public Speaking
Cross Functional Team Leadership
Teaching
Research
Research and Development
Chris Wegener Summary
Chris Wegener, based in Libertyville, IL, US, is currently a Director, Cell Therapy R and D at Fresenius Kabi USA. Chris Wegener brings experience from previous roles at Fresenius Kabi USA and Fenwal, Inc., a Fresenius Kabi Company. Chris Wegener holds a 2008 - 2009 MS in Biomedical Engineering @ University of Wisconsin-Madison. With a robust skill set that includes Biomedical Engineering, Medical Device Product Development, Matlab, Telelogic DOORS, Concept Design and more. Chris Wegener has 2 emails and 1 mobile phone numbers on RocketReach.
Get contact details of over 700M profiles across 60M companies - all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.